Insiders · MRTX

MRTX insider transactions

Mirati Therapeutics Inc. (MRTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for MRTX

• 864d
  Boxer Capital, Llc returned 6,859,544 shares to the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 866d
  Cherrington Julie M returned 11,252 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 866d
  Sharp Shalini returned 16,222 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 866d
  Davis Aaron I. returned 54,325 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 866d
  Hasnain Faheem returned 24,752 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 866d
  Ondrey Aaron returned 39,461 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 866d
  Carter Bruce L A returned 17,273 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 866d
  Johnson Craig A returned 17,273 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 866d
  Moriarty John B returned 72,335 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 866d
  Hickey Benjamin returned 117,028 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 866d
  Martinez Maria E returned 17,273 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 866d
  Sandler Alan B. returned 79,865 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 866d
  Baum Charles M returned 237,871 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 866d
  Christensen Jamie returned 154,996 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 866d
  Gallagher Carol Giltner returned 14,363 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 871d
  Hickey Benjamin sold $94,255 worth of shares (1,597 units at $59.02), decreasing direct ownership by 1% to 117,028 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 871d
  Christensen Jamie sold $94,255 worth of shares (1,597 units at $59.02), decreasing direct ownership by 1% to 155,927 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 880d
  Hickey Benjamin sold $123,143 worth of shares (2,090 units at $58.92), decreasing direct ownership by 2% to 118,625 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 884d
  Christensen Jamie sold $90,038 worth of shares (1,531 units at $58.81), decreasing direct ownership by 0.96% to 157,135 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 886d
  Davis Aaron I. was granted 6,808 shares, increasing direct ownership by 14% to 54,325 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 886d
  Johnson Craig A was granted 6,808 shares, increasing direct ownership by 65% to 17,273 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 886d
  Martinez Maria E was granted 6,808 shares, increasing direct ownership by 65% to 17,273 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 886d
  Gallagher Carol Giltner was granted 6,808 shares, increasing direct ownership by 90% to 14,363 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 886d
  Sharp Shalini was granted 6,808 shares, increasing direct ownership by 72% to 16,222 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 886d
  Cherrington Julie M was granted 6,808 shares, increasing direct ownership by 153% to 11,252 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 886d
  Hasnain Faheem was granted 9,702 shares, increasing direct ownership by 64% to 24,752 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 886d
  Carter Bruce L A was granted 6,808 shares, increasing direct ownership by 65% to 17,273 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 886d
  Hickey Benjamin was granted 17,021 shares, increasing direct ownership by 16% to 120,715 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 886d
  Christensen Jamie was granted 17,021 shares, increasing direct ownership by 12% to 158,666 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 886d
  Sandler Alan B. was granted 17,021 shares, increasing direct ownership by 27% to 79,318 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 886d
  Ondrey Aaron was granted 17,021 shares, increasing direct ownership by 76% to 39,461 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 886d
  Baum Charles M was granted 20,425 shares, increasing direct ownership by 9% to 247,700 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 893d
  New insider Ecor1 Capital, Llc claimed ownership of 7,396,979 shares (SEC Form 3)

  3 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 901d
  Christensen Jamie sold $137,252 worth of shares (2,387 units at $57.50), decreasing direct ownership by 2% to 141,645 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 906d
  Hickey Benjamin sold $125,807 worth of shares (2,220 units at $56.67), decreasing direct ownership by 2% to 103,694 units (SEC Form 4)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 999d
  SEC Form 4: Christensen Jamie sold $85,084 worth of shares (2,388 units at $35.63), decreasing direct ownership by 2% to 144,032 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 999d
  SEC Form 4: Ondrey Aaron was granted 8,412 shares, increasing direct ownership by 60% to 22,440 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 999d
  SEC Form 3: New insider Ondrey Aaron claimed ownership of 14,028 shares

  3 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1027d
  SEC Form 4: Boxer Capital, Llc bought $34,999,449 worth of shares (1,258,973 units at $27.80)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1027d
  SEC Form 4: Boxer Capital, Llc bought $34,999,449 worth of shares (1,258,973 units at $27.80)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1028d
  SEC Form 4: Hasnain Faheem bought $299,990 worth of shares (10,791 units at $27.80)

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1032d
  SEC Form 4: Stelzer Laurie was granted 22,297 shares, increasing direct ownership by 28% to 102,312 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1032d
  SEC Form 4: Baum Charles M was granted 54,054 shares, increasing direct ownership by 31% to 227,275 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1032d
  SEC Form 4: Hickey Benjamin was granted 22,297 shares, increasing direct ownership by 27% to 105,914 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1032d
  SEC Form 4: Moriarty John B was granted 22,297 shares, increasing direct ownership by 45% to 71,660 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1032d
  SEC Form 4: Christensen Jamie was granted 22,297 shares, increasing direct ownership by 18% to 146,420 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1032d
  SEC Form 4: Sandler Alan B. was granted 22,297 shares, increasing direct ownership by 56% to 62,297 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1080d
  SEC Form 4 filed by Gallagher Carol Giltner

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1080d
  SEC Form 3: New insider Gallagher Carol Giltner claimed no ownership of stock in the company

  3 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1080d
  SEC Form 3: New insider Moriarty John B claimed ownership of 49,363 shares

  3 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1101d
  SEC Form 4 filed by Stelzer Laurie

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1110d
  SEC Form 4 filed by Christensen Jamie

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1230d
  SEC Form 4: Davis Aaron I. was granted 4,444 shares, increasing direct ownership by 10% to 47,517 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1230d
  SEC Form 4: Baum Charles M was granted 4,444 shares, increasing direct ownership by 3% to 173,221 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1230d
  SEC Form 4: Johnson Craig A was granted 4,444 shares, increasing direct ownership by 74% to 10,465 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1230d
  SEC Form 4: Cherrington Julie M was granted 4,444 shares

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1230d
  SEC Form 4: Hasnain Faheem was granted 6,333 shares, increasing direct ownership by 73% to 15,050 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1230d
  SEC Form 4: Sharp Shalini was granted 4,444 shares, increasing direct ownership by 89% to 9,414 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1230d
  SEC Form 4: Christensen Jamie was granted 26,864 shares, increasing direct ownership by 27% to 124,742 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)
• 1230d
  SEC Form 4: Meek David D. was granted 89,379 shares, increasing direct ownership by 145% to 151,171 units

  4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)